Publikationen (37) Publikationen von JAVIER ORCAJO RINCÓN

2024

  1. Clinical practice guidelines for the treatment of Ewing sarcoma (Spanish Sarcoma Research Group-GEIS)

    Clinical and Translational Oncology

  2. Genotoxic effects of ablative treatment with I-131 determined through the analysis of dicentric chromosomes in peripheral blood lymphocytes. Can it influence the clinical management of patients with differentiated thyroid carcinoma?

    Radiation Physics and Chemistry, Vol. 223

2023

  1. Maximum tumor-absorbed dose measured by voxel-based multicompartmental dosimetry as a response predictor in yttrium-90 radiation segmentectomy for hepatocellular carcinoma

    EJNMMI Physics, Vol. 10, Núm. 1

  2. Portal hypertension increases the risk of hepatic decompensation after 90Yttrium radioembolization in patients with hepatocellular carcinoma: a cohort study

    Therapeutic Advances in Gastroenterology, Vol. 16

  3. Relevance of [18F]FDG-PET/CT in the detection of colon pathology in patients studied by bacteriemia or infectious endocarditis caused by enteropathogenic microorganisms

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 42, Núm. 3, pp. 139-146

2022

  1. Are the radiation segmentectomy results in hepatocellular carcinoma reproducible? What factors guarantee success?

    Revista Espanola de Medicina Nuclear e Imagen Molecular

  2. Clinical application of [18F]FDG PET/CT in follicular lymphoma

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 3, pp. 202-212

  3. Contributions of nuclear medicine to malignant musculoskeletal tumor disease in children

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 6, pp. 395-407

  4. Is everything said in the treatment of colorectal cancer liver metastases with radioembolization, after the EPOCH results?

    Revista Espanola de Medicina Nuclear e Imagen Molecular

  5. Review of imaging techniques for evaluating morphological and functional responses to the treatment of bone metastases in prostate and breast cancer

    Clinical and Translational Oncology, Vol. 24, Núm. 7, pp. 1290-1310

  6. The role of PSMA radioligands in the diagnosis and treatment of prostate carcinoma

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 2, pp. 126-135

2021

  1. Efficacy and safety of Yttrium-90 radioembolization in the treatment of neuroendocrine liver metastases. Long-term monitoring and impact on survival

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 40, Núm. 2, pp. 82-90

  2. GEIS-SEHOP clinical practice guidelines for the treatment of rhabdomyosarcoma

    Clinical and Translational Oncology, Vol. 23, Núm. 12, pp. 2460-2473

  3. Identification, by 99mTc-HDP-SPECT/CT imaging, of unknown pulmonary metastases in patients with osteosarcoma

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 40, Núm. 5, pp. 325-327

2020

  1. FDG PET/CT in colorectal cancer

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 1, pp. 57-66

  2. Functional image in soft tissue sarcomas: An update of the indications of 18F-FDG-PET/CT

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 4, pp. 233-243

  3. Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM

    Clinical and Translational Oncology, Vol. 22, Núm. 5, pp. 647-662

  4. Rapidly progressive dementia associated with BK virus infection in an octogenarian woman

    Revista Espanola de Geriatria y Gerontologia, Vol. 55, Núm. 3, pp. 185-186

2019

  1. 18F-FDG PET/CT in locally advanced cervical cancer: A review

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 38, Núm. 1, pp. 59-68

  2. Early Lymphocyte Recovery and Sarcomas: An Extensively Available and Potentially Useful Biomarker as a Good Prognosis Factor

    51st Congress of the International Society of Paediatric Oncology (SIOP)